Looks like they have started their discussions for cardiovascular protection. Would love to know which big pharma they are in talks with. I reason why I reckon management and major share holders are soaking up the shares. Still think within 12-18 months they will get a multi billion dollar licensee
“Big Pharma is looking at cardio protection in particular and we think our novel molecule … should attract interest,” NYR CEO
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
37.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $78.03M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 1642 | 37.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 37.0¢ | 682527 | 2 |
View Market Depth
| Last trade - 07.10am 01/08/2025 (20 minute delay) ? |
| NYR (ASX) Chart |
Day chart unavailable